Nxera Pharma Co (TSE:4565) FCF Margin %: -105.01% (As of Mar. 2026)

What is Nxera Pharma Co FCF Margin %?

Nxera Pharma Co TSE:4565 +1.81% 73 FCF Margin % is -105.01% as of Mar. 2026. GuruFocus rates TSE:4565 with a GF Score™ of 73/100 and a GF Value™ of 円1,308.23 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 959 Biotechnology companies, Nxera Pharma Co ranks better than 58.5% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Nxera Pharma Co's Free Cash Flow for the three months ended in Mar. 2026 was 円-6,977 Mil. Nxera Pharma Co's Revenue for the three months ended in Mar. 2026 was 円6,644 Mil. Therefore, Nxera Pharma Co's FCF Margin % for the quarter that ended in Mar. 2026 was -105.01%.

As of today, Nxera Pharma Co's current FCF Yield % is -12.14%.

The historical rank and industry rank for Nxera Pharma Co's FCF Margin % or its related term are showing as below:

TSE:4565' s FCF Margin % Range Over the Past 10 Years
Min: -47.97 Med: 35.71 Max: 66.26
Current: -35.86

During the past 13 years, the highest FCF Margin % of Nxera Pharma Co was 66.26%. The lowest was -47.97%. And the median was 35.71%.

TSE:4565's FCF Margin % is ranked better than
58.5% of 959 companies
in the Biotechnology industry
Industry Median: -84.65 vs TSE:4565: -35.86

Nxera Pharma Co FCF Margin % Related Terms

Nxera Pharma Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Nxera Pharma Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nxera Pharma Co FCF Margin % Chart

Nxera Pharma Co Annual Data

Trend

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Margin %

Get a 7-Day Free Trial

38.92

61.98

-47.97

-32.10

-11.12

Nxera Pharma Co Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Margin %	Get a 7-Day Free Trial															5.28	-3.20	-45.62	-3.77	-105.01

TSE:4565 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Nxera Pharma Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's FCF Margin % falls into.

Save Embed

73GF Score

Nxera Pharma Co Ltd TSE:4565

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Nxera Pharma Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Nxera Pharma Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-3293	/	29615
	=	-11.12 %

Nxera Pharma Co's FCF Margin for the quarter that ended in Mar. 2026 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-6977	/	6644
	=	-105.01 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -105.01% mean?

Nxera Pharma Co (TSE:4565) has a FCF Margin % of -105.01% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nxera Pharma Co and its competitors. According to the industry distribution chart, Nxera Pharma Co ranks #398 out of 959 companies in the Biotechnology industry, placing it in the top 41.5%.

Is Nxera Pharma Co's FCF Margin % too high?

Nxera Pharma Co's current FCF Margin % is -105.01%. Based on the distribution chart, Nxera Pharma Co ranks #398 out of 959 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Nxera Pharma Co has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.

How does Nxera Pharma Co's FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Nxera Pharma Co ranks #398 out of 959 companies for FCF Margin %. This puts Nxera Pharma Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Nxera Pharma Co and its competitors. Nxera Pharma Co's current FCF Margin % is -105.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Nxera Pharma Co stock overvalued right now?

Based on GuruFocus' analysis, Nxera Pharma Co (TSE:4565) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,308.23, compared to a current price of 円954.00 — trading 27.1% below its estimated fair value. The current FCF Margin % is -105.01%. Nxera Pharma Co's overall GF Score™ is 73/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Nxera Pharma Co (TSE:4565), the current FCF Margin % is -105.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nxera Pharma Co (TSE:4565) Overvalued in 2026?

Based on GuruFocus' analysis, Nxera Pharma Co stock appears to be undervalued. The current stock price of 円954.00 is trading 27.1% below its estimated GF Value™ of 円1,308.23. GuruFocus considers Nxera Pharma Co to be Modestly Undervalued.

Key valuation signals for TSE:4565:

FCF Margin %: -105.01%
GF Value™: 円1,308.23 vs. price of 円954.00 (27.1% below fair value)
GF Score™: 73/100 with 7 warning signs

No single metric tells the full story. See the TSE:4565 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nxera Pharma Co Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:4592 TSE:4588 TSE:4974 TSE:2160 TSE:4587 TSE:4593 TSE:4894 TSE:219A TSE:504A TSE:7774 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY RVMD ASX:CSL ONC XKRX:068270

Other Exchanges SOLTF:USA

Address Midtown East, 9-7-2 Akasaka Minato-ku, Tokyo, JPN, 107-0052

Website https://www.nxera.life

Nxera Pharma Co Ltd is a science and technology-led biopharmaceutical company. Its activities are drug discovery, drug development and the commercialization of pharmaceutical products. The focus is to discover new medicines for unmet medical needs, including novel small molecules, peptides and therapeutic antibodies targeting G Protein Coupled Receptors (GPCRs).

73GF Score

Get the complete analysis for TSE:4565

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円954.00

Price

円1,308.23

GF Value

View TSE:4565 Analysis

See FCF Margin % data for all stocks →